November 12, 2020
Avicenna.AI Provides Cina Head AI Triage Solution for Canon’s Automation Platform
November 12, 2020—Avicenna.AI, a medical imaging artificial intelligence (AI) specialist based in La Ciotat, France, announced a partnership with Canon Medical Systems Corporation to deliver a fully integrated stroke detection AI solution for Canon’s automation platform.
According to Avicenna.AI, the company will provide Canon with its FDA-approved Cina Head triage AI solution for neurovascular emergencies. Cina Head uses a combination of deep learning and machine learning technologies to automatically detect and prioritize acute intracranial hemorrhage (ICH) and large vessel occlusion (LVO) cases within 20 seconds, alerting the radiologist within their existing systems and workflow.
The company stated that Cina’s ICH detection capability was validated using data from 814 cases conducted at > 250 imaging centers across the United States, with 96% accuracy, 91.4% sensitivity, and 97.5% specificity. The product’s LVO detection capability was validated based on 476 cases, with 97.7% accuracy, 97.9% sensitivity, and 97.6% specificity.
Avicenna.AI announced FDA approval of Cina Head in July 2020. The company was founded by Cyril Di Grandi and radiologist Peter Chang, MD, in 2018.